Selected research
Market Structure
Global Pharma-Grade Nitric Oxide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharma-Grade Nitric Oxide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pharma-Grade Nitric Oxide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharma-Grade Nitric Oxide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharma-Grade Nitric Oxide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharma-Grade Nitric Oxide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharma-Grade Nitric Oxide include Praxair, Novoteris, Inomax and Air Liquide, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pharma-Grade Nitric Oxide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharma-Grade Nitric Oxide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharma-Grade Nitric Oxide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharma-Grade Nitric Oxide market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharma-Grade Nitric Oxide Segment by Company
Praxair
Novoteris
Inomax
Air Liquide
Pharma-Grade Nitric Oxide Segment by Type
99.92% Purity
99.99% Purity
Pharma-Grade Nitric Oxide Segment by Application
Hospitals
Healthcare Centers
Others
Pharma-Grade Nitric Oxide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma-Grade Nitric Oxide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma-Grade Nitric Oxide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma-Grade Nitric Oxide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pharma-Grade Nitric Oxide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharma-Grade Nitric Oxide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharma-Grade Nitric Oxide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pharma-Grade Nitric Oxide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 99.92% Purity
- 99.99% Purity
Applications
- Hospitals
- Healthcare Centers
- Others
Companies covered
- Praxair
- Novoteris
- Inomax
- Air Liquide
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharma-Grade Nitric Oxide Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharma-Grade Nitric Oxide Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pharma-Grade Nitric Oxide Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pharma-Grade Nitric Oxide Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pharma-Grade Nitric Oxide Market Dynamics
- 2.1 Pharma-Grade Nitric Oxide Industry Trends
- 2.2 Pharma-Grade Nitric Oxide Industry Drivers
- 2.3 Pharma-Grade Nitric Oxide Industry Opportunities and Challenges
- 2.4 Pharma-Grade Nitric Oxide Industry Restraints
3 Pharma-Grade Nitric Oxide Market by Manufacturers
- 3.1 Global Pharma-Grade Nitric Oxide Revenue by Manufacturers (2021-2026)
- 3.2 Global Pharma-Grade Nitric Oxide Sales by Manufacturers (2021-2026)
- 3.3 Global Pharma-Grade Nitric Oxide Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pharma-Grade Nitric Oxide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharma-Grade Nitric Oxide Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pharma-Grade Nitric Oxide Manufacturers, Product Type & Application
- 3.7 Global Pharma-Grade Nitric Oxide Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pharma-Grade Nitric Oxide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pharma-Grade Nitric Oxide Players Market Share by Revenue in 2025
- 3.8.3 2025 Pharma-Grade Nitric Oxide Tier 1, Tier 2, and Tier 3
4 Pharma-Grade Nitric Oxide Market by Type
- 4.1 Pharma-Grade Nitric Oxide Type Introduction
- 4.1.1 99.92% Purity
- 4.1.2 99.99% Purity
- 4.2 Global Pharma-Grade Nitric Oxide Sales by Type
- 4.2.1 Global Pharma-Grade Nitric Oxide Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharma-Grade Nitric Oxide Sales by Type (2021-2032)
- 4.2.3 Global Pharma-Grade Nitric Oxide Sales Market Share by Type (2021-2032)
- 4.3 Global Pharma-Grade Nitric Oxide Revenue by Type
- 4.3.1 Global Pharma-Grade Nitric Oxide Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pharma-Grade Nitric Oxide Revenue by Type (2021-2032)
- 4.3.3 Global Pharma-Grade Nitric Oxide Revenue Market Share by Type (2021-2032)
5 Pharma-Grade Nitric Oxide Market by Application
- 5.1 Pharma-Grade Nitric Oxide Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Healthcare Centers
- 5.1.3 Others
- 5.2 Global Pharma-Grade Nitric Oxide Sales by Application
- 5.2.1 Global Pharma-Grade Nitric Oxide Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharma-Grade Nitric Oxide Sales by Application (2021-2032)
- 5.2.3 Global Pharma-Grade Nitric Oxide Sales Market Share by Application (2021-2032)
- 5.3 Global Pharma-Grade Nitric Oxide Revenue by Application
- 5.3.1 Global Pharma-Grade Nitric Oxide Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pharma-Grade Nitric Oxide Revenue by Application (2021-2032)
- 5.3.3 Global Pharma-Grade Nitric Oxide Revenue Market Share by Application (2021-2032)
6 Global Pharma-Grade Nitric Oxide Sales by Region
- 6.1 Global Pharma-Grade Nitric Oxide Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharma-Grade Nitric Oxide Sales by Region (2021-2032)
- 6.2.1 Global Pharma-Grade Nitric Oxide Sales by Region (2021-2026)
- 6.2.2 Global Pharma-Grade Nitric Oxide Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharma-Grade Nitric Oxide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pharma-Grade Nitric Oxide Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pharma-Grade Nitric Oxide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pharma-Grade Nitric Oxide Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pharma-Grade Nitric Oxide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pharma-Grade Nitric Oxide Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pharma-Grade Nitric Oxide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pharma-Grade Nitric Oxide Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pharma-Grade Nitric Oxide Revenue by Region
- 7.1 Global Pharma-Grade Nitric Oxide Revenue by Region
- 7.1.1 Global Pharma-Grade Nitric Oxide Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pharma-Grade Nitric Oxide Revenue by Region (2021-2026)
- 7.1.3 Global Pharma-Grade Nitric Oxide Revenue by Region (2027-2032)
- 7.1.4 Global Pharma-Grade Nitric Oxide Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pharma-Grade Nitric Oxide Revenue (2021-2032)
- 7.2.2 North America Pharma-Grade Nitric Oxide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pharma-Grade Nitric Oxide Revenue (2021-2032)
- 7.3.2 Europe Pharma-Grade Nitric Oxide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pharma-Grade Nitric Oxide Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pharma-Grade Nitric Oxide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pharma-Grade Nitric Oxide Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pharma-Grade Nitric Oxide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Praxair
- 8.1.1 Praxair Company Information
- 8.1.2 Praxair Business Overview
- 8.1.3 Praxair Pharma-Grade Nitric Oxide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Praxair Pharma-Grade Nitric Oxide Product Portfolio
- 8.1.5 Praxair Recent Developments
- 8.2 Novoteris
- 8.2.1 Novoteris Company Information
- 8.2.2 Novoteris Business Overview
- 8.2.3 Novoteris Pharma-Grade Nitric Oxide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Novoteris Pharma-Grade Nitric Oxide Product Portfolio
- 8.2.5 Novoteris Recent Developments
- 8.3 Inomax
- 8.3.1 Inomax Company Information
- 8.3.2 Inomax Business Overview
- 8.3.3 Inomax Pharma-Grade Nitric Oxide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Inomax Pharma-Grade Nitric Oxide Product Portfolio
- 8.3.5 Inomax Recent Developments
- 8.4 Air Liquide
- 8.4.1 Air Liquide Company Information
- 8.4.2 Air Liquide Business Overview
- 8.4.3 Air Liquide Pharma-Grade Nitric Oxide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Air Liquide Pharma-Grade Nitric Oxide Product Portfolio
- 8.4.5 Air Liquide Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pharma-Grade Nitric Oxide Value Chain Analysis
- 9.1.1 Pharma-Grade Nitric Oxide Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pharma-Grade Nitric Oxide Production Mode & Process
- 9.2 Pharma-Grade Nitric Oxide Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharma-Grade Nitric Oxide Distributors
- 9.2.3 Pharma-Grade Nitric Oxide Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst